Melanoma coordinates general and cell-specific mechanisms to promote methotrexate resistance. 2012

Magalí Sáez-Ayala, and María Piedad Fernández-Pérez, and María F Montenegro, and Luis Sánchez-del-Campo, and Soledad Chazarra, and Antonio Piñero-Madrona, and Juan Cabezas-Herrera, and José Neptuno Rodríguez-López
Department of Biochemistry and Molecular Biology A, School of Biology, University of Murcia, Murcia, Spain.

Melanoma, the most aggressive form of skin cancer, is notoriously resistant to all current modalities of cancer therapy, including to the drug methotrexate. Melanosomal sequestration and cellular exportation of methotrexate have been proposed to be important melanoma-specific mechanisms that contribute to the resistance of melanoma to methotrexate. In addition, other mechanisms of resistance that are present in most epithelial cancer cells are also operative in melanoma. This report elucidates how melanoma orchestrates these mechanisms to become extremely resistant to methotrexate, where both E2F1 and checkpoint kinase 1 (Chk1), two molecules with dual roles in survival/apoptosis, play prominent roles. The results indicated that MTX induced the depletion of dihydrofolate in melanoma cells, which stimulated the transcriptional activity of E2F1. The elevate expression of dihydrofolate reductase and thymidylate synthase, two E2F1-target genes involved in folate metabolism and required for G(1) progression, favored dTTP accumulation, which promoted DNA single strand breaks and the subsequent activation of Chk1. Under these conditions, melanoma cells are protected from apoptosis by arresting their cell cycle in S phase. Excess of dTTP could also inhibit E2F1-mediated apoptosis in melanoma cells.

UI MeSH Term Description Entries
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005492 Folic Acid A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. Pteroylglutamic Acid,Vitamin M,Folacin,Folate,Folic Acid, (D)-Isomer,Folic Acid, (DL)-Isomer,Folic Acid, Calcium Salt (1:1),Folic Acid, Monopotassium Salt,Folic Acid, Monosodium Salt,Folic Acid, Potassium Salt,Folic Acid, Sodium Salt,Folvite,Vitamin B9,B9, Vitamin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071877 Checkpoint Kinase 1 A serine/threonine-specific protein kinase which is encoded by the CHEK1 gene in humans. Checkpoint kinase 1 (also known as Chk1) coordinates DNA damage response and cell cycle checkpoint response. Under these conditions, activation of Chk1 results in the initiation of cell cycle checkpoints, cell cycle arrest, DNA repair and cell death, to prevent damaged cells from progressing through the cell cycle. Checkpoint-1 Kinase,Chk1 Kinase,Chk1 Protein Kinase,Protein Kinase, Chk1

Related Publications

Magalí Sáez-Ayala, and María Piedad Fernández-Pérez, and María F Montenegro, and Luis Sánchez-del-Campo, and Soledad Chazarra, and Antonio Piñero-Madrona, and Juan Cabezas-Herrera, and José Neptuno Rodríguez-López
January 1998, Life sciences,
Magalí Sáez-Ayala, and María Piedad Fernández-Pérez, and María F Montenegro, and Luis Sánchez-del-Campo, and Soledad Chazarra, and Antonio Piñero-Madrona, and Juan Cabezas-Herrera, and José Neptuno Rodríguez-López
May 2003, Zhonghua er ke za zhi = Chinese journal of pediatrics,
Magalí Sáez-Ayala, and María Piedad Fernández-Pérez, and María F Montenegro, and Luis Sánchez-del-Campo, and Soledad Chazarra, and Antonio Piñero-Madrona, and Juan Cabezas-Herrera, and José Neptuno Rodríguez-López
June 1991, Haematologica,
Magalí Sáez-Ayala, and María Piedad Fernández-Pérez, and María F Montenegro, and Luis Sánchez-del-Campo, and Soledad Chazarra, and Antonio Piñero-Madrona, and Juan Cabezas-Herrera, and José Neptuno Rodríguez-López
December 1985, JPMA. The Journal of the Pakistan Medical Association,
Magalí Sáez-Ayala, and María Piedad Fernández-Pérez, and María F Montenegro, and Luis Sánchez-del-Campo, and Soledad Chazarra, and Antonio Piñero-Madrona, and Juan Cabezas-Herrera, and José Neptuno Rodríguez-López
March 2019, Journal of the European Academy of Dermatology and Venereology : JEADV,
Magalí Sáez-Ayala, and María Piedad Fernández-Pérez, and María F Montenegro, and Luis Sánchez-del-Campo, and Soledad Chazarra, and Antonio Piñero-Madrona, and Juan Cabezas-Herrera, and José Neptuno Rodríguez-López
January 1996, Stem cells (Dayton, Ohio),
Magalí Sáez-Ayala, and María Piedad Fernández-Pérez, and María F Montenegro, and Luis Sánchez-del-Campo, and Soledad Chazarra, and Antonio Piñero-Madrona, and Juan Cabezas-Herrera, and José Neptuno Rodríguez-López
January 1996, The oncologist,
Magalí Sáez-Ayala, and María Piedad Fernández-Pérez, and María F Montenegro, and Luis Sánchez-del-Campo, and Soledad Chazarra, and Antonio Piñero-Madrona, and Juan Cabezas-Herrera, and José Neptuno Rodríguez-López
March 2018, eLife,
Magalí Sáez-Ayala, and María Piedad Fernández-Pérez, and María F Montenegro, and Luis Sánchez-del-Campo, and Soledad Chazarra, and Antonio Piñero-Madrona, and Juan Cabezas-Herrera, and José Neptuno Rodríguez-López
July 1994, International journal of cancer,
Magalí Sáez-Ayala, and María Piedad Fernández-Pérez, and María F Montenegro, and Luis Sánchez-del-Campo, and Soledad Chazarra, and Antonio Piñero-Madrona, and Juan Cabezas-Herrera, and José Neptuno Rodríguez-López
January 2018, Science signaling,
Copied contents to your clipboard!